Volume 63, Issue 4, Pages (April 2013)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

Volume 68, Issue 6, Pages (December 2015)

Volume 68, Issue 4, Pages (October 2015)

Volume 62, Issue 3, Pages (September 2012)

Volume 64, Issue 3, Pages (September 2013)

Volume 58, Issue 2, Pages (August 2010)

Volume 62, Issue 4, Pages (October 2012)

Testosterone Therapy in Men With Prostate Cancer

Volume 63, Issue 5, Pages (May 2013)

Volume 58, Issue 1, Pages (July 2010)

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Volume 60, Issue 2, Pages (August 2011)

Volume 57, Issue 6, Pages (June 2010)

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer Francesco Cantiello, Giorgio.

European Urology Oncology

Volume 49, Issue 2, Pages (February 2006)

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 3, Pages (September 2015)

Volume 69, Issue 1, Pages (January 2016)

Volume 70, Issue 6, Pages (December 2016)

Volume 51, Issue 3, Pages (March 2007)

European Urology Oncology

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 4, Pages (April 2012)

Volume 66, Issue 3, Pages (September 2014)

Volume 67, Issue 4, Pages (April 2015)

Volume 63, Issue 1, Pages (January 2013)

Volume 59, Issue 6, Pages (June 2011)

Volume 68, Issue 5, Pages (November 2015)

Nomograms for Bladder Cancer

Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 4, Pages (April 2012)

Volume 53, Issue 4, Pages (April 2008)

Volume 57, Issue 4, Pages (April 2010)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Volume 71, Issue 6, Pages (June 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 5, Pages (May 2012)

Volume 66, Issue 2, Pages (August 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 62, Issue 2, Pages (August 2012)

Volume 59, Issue 1, Pages (January 2011)

Volume 60, Issue 6, Pages (December 2011)

Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.

Volume 56, Issue 5, Pages (November 2009)

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 68, Issue 4, Pages (October 2015)

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Volume 52, Issue 6, Pages (December 2007)

Testicular Cancer Variations in Time and Space in Europe

Volume 49, Issue 4, Pages (April 2006)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology Oncology

European Urology is “Your” Journal

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

The Start-Up of the Platinum Journal: A Fascinating Challenge

Volume 50, Issue 5, Pages (November 2006)

Volume 54, Issue 1, Pages (July 2008)

Volume 52, Issue 4, Pages (October 2007)

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 52, Issue 1, Pages (July 2007)

Volume 54, Issue 1, Pages (July 2008)

How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder? Shahrokh Shariat, Paolo Gontero, James.

Presentation transcript:

Volume 63, Issue 4, Pages 724-732 (April 2013) Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non– muscle-invasive Bladder Cancer Michael Rink, Helena Furberg, Emily C. Zabor, Evanguelos Xylinas, Marko Babjuk, Armin Pycha, Yair Lotan, Pierre I. Karakiewicz, Giacomo Novara, Brian D. Robinson, Francesco Montorsi, Felix K. Chun, Douglas S. Scherr, Shahrokh F. Shariat European Urology Volume 63, Issue 4, Pages 724-732 (April 2013) DOI: 10.1016/j.eururo.2012.08.025 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Outcomes of 2043 patients with non–muscle-invasive bladder cancer treated with transurethral resection of the bladder according to cigarette smoking status and cumulative smoking exposure: Cumulative incidence of disease recurrence by (A) smoking status and (B) cumulative smoking exposure; cumulative incidence of disease progression by (C) smoking status and (D) cumulative smoking exposure; Kaplan-Meier estimates of overall survival by (E) smoking status and (F) cumulative smoking exposure. OS=overall survival. European Urology 2013 63, 724-732DOI: (10.1016/j.eururo.2012.08.025) Copyright © 2012 European Association of Urology Terms and Conditions